| Net Cash Provided by (Used in) Operating Activities |
$6,837,000 |
USD |
-384% |
Q3 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,341,000 |
USD |
41% |
Q3 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$12,012,000 |
USD |
44% |
Q3 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
16,288,284 |
shares |
-2.9% |
Q4 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$56,229,000 |
USD |
64% |
Q4 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
-100% |
Q3 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q2 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$24,900,000 |
USD |
-4.3% |
Q2 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$3,080,000 |
USD |
40% |
Q3 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$99,871,000 |
USD |
8.8% |
Q4 2025 |
Q2 2025 |
| Deferred Income Tax Expense (Benefit) |
$1,009,000 |
USD |
|
Q3 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,003,000 |
USD |
-7.2% |
Q2 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$6,853,000 |
USD |
-0.12% |
Q2 2025 |
FY 2025 |
| Amortization of Intangible Assets |
$1,800,000 |
USD |
0% |
Q4 2025 |
Q2 2025 |
| Depreciation, Depletion and Amortization |
$9,600,000 |
USD |
11% |
Q4 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$24,900,000 |
USD |
-4.3% |
Q2 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$3,437,000 |
USD |
18% |
Q4 2025 |
Q2 2025 |
| Interest Expense |
$1,087,000 |
USD |
-60% |
Q4 2025 |
Q2 2025 |